Recent Advances in Liver Cirrhosis Related Complications provides comprehensive coverage on the contemporary management of liver cirrhosis related complications and future directions for the field. Content covers epidemiology, diagnosis, risk stratification, and pathophysiology. Contents include coverage of the gut microbiota, ascites, and gastrointestinal bleeding as well as the challenges of hepatic encephalopathy, acute kidney injury, bacterial infections, coagulation abnormality, and venous thromboembolism, amongst others. This is the perfect resource for practicing gastroenterologists and hepatologists as well as family physicians and investigators who are skilled at the management of liver cirrhosis and its complications.
1. Epidemiological insights into liver cirrhosis
Nahum Mendez-Sanchez, Mariana M. Ramrez-Meja and Deyanira Kusulas-Delint
2. Diagnosis and risk stratification of liver cirrhosis
Hitoshi Maruyama
3. Pathophysiology of portal hypertension in liver cirrhosis
Mauro Bernardi and Giacomo Zaccherini
4. Gut microbiota in liver cirrhosis
Cyriac Abby Philips and Tharun Tom Oommen
5. Ascites in liver cirrhosis
Xianxian Zhang, Caie Wang, Alastair OBrien and Xingshun Qi
6. Gastrointestinal bleeding in liver cirrhosis
Amerah Taleb and Mostafa Ibrahim
7. Hepatic encephalopathy
Jessica Faccioli, Stefania Gioia, Silvia Nardelli and Lorenzo Ridola
8. Acute kidney injury in liver cirrhosis
Florence Wong
9. Bacterial infections in liver cirrhosis
Massimo Primignani
10. Coagulation abnormality in liver cirrhosis
Elisa Zanatta, Marco Senzolo, Elena Campello, Paolo Simioni and Alberto
Zanetto
11. Splanchnic vein thrombosis in liver cirrhosis
Erica Villa and Stefano Gitto
12. Splenomegaly and hypersplenism in liver cirrhosis
Rita Noversa de Sousa and Filipe Gaio Nery
13. Pulmonary complications in liver cirrhosis
Thierry Thevenot, Sarah Raevens, Avinash Aujayeb, Jean-Francø ois Cadranel,
Bubu A. Banini and Hilary M. Dubrock
Subchapter 13.1: Portopulmonary
Subchapter 13.2: Hepatic hydrothorax
14. Cirrhotic cardiomyopathy
Olivia Greenham and Rajeshwar Prosad Mookerjee
15. Acute-on-chronic liver failure
Shahid Habib
16. Hepatogenous diabetes in liver cirrhosis
Jose K. Hernandez Roman, Michael Attanasi and Sanjaya K. Satapathy
17. Sarcopenia in liver cirrhosis
Sara Haj Ali, Tarek Mazzawi, Awni Abu Sneineh and Faten Marji
18. Osteoporosis in liver cirrhosis
Talles Bazeia Lima, Livia Alves Amaral Santos and Fernando Gomes Romeiro
19. Hepatocellular carcinoma
Lampros Chrysavgis and Evangelos Cholongitas
20. Prognostic models of cirrhotic patients
Xiaoting Song, Yue Yinast;, Hong You and Xingshun Qi
Dr. Xingshun Qi is the director at the Department of Gastroenterology of the General Hospital of Northern Theater Command. His major research interests include clinical research in the etiology, diagnosis, and management of liver cirrhosis, portal hypertension, and hepatocellular carcinoma. He is serving as a senior editorial board member of BMC Gastroenterology, an academic editor of Canadian Journal of Gastroenterology and Hepatology, an associate editor of Frontiers in Medicine, and an editorial board member of Therapeutic Advances in Gastroenterology. He has edited 11 English-language books and published more than 400 papers in peer-reviewed journals. Hong You practices in Beijing, China. Her top areas of expertise are schistosomiasis, distomatosis, cirrhosis, hepatitis B, and liver transplant. Her clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies. She has co-authored 358 articles in peer reviewed medical journals and participated in 8 clinical trials over the past 15 years.
